Column GROUP Iii-a, L.P., 10% Owner, Ten Percent Owner Other, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 145,166 shares at $17.99 ($2.6M) on 2020-07-27, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.93 | 68,749 | $1.2M | 47.4% |
| 2 | $17.93 | 68,749 | $1.2M | 47.4% |
| 3 | $17.99 | 3,834 | $69K | 2.6% |
| 4 | $17.99 | 3,834 | $69K | 2.6% |
| Total | $17.93 avg | 145,166 | $2.6M | 100% |
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |